Vice President, Regulatory Affairs
Nataskia Lampe is a seasoned leader in the biotechnology and biopharmaceutical industries. She has decades of experience advancing the development of cutting-edge therapies in Oncology, Renal, Pulmonary, Cystic Fibrosis, Neuroscience, Immunology and Fibrosis through Global Regulatory Affairs and Asset Strategy. Prior to joining Pieris, Ms. Lampe spent 9 years at Abbvie, where she held positions as an Asset Strategy Leader and Global Regulatory Leader across multiple therapeutic areas. In Asset Strategy, she led cross functional teams of Clinical, Commercial, Market Access, CMC, Regulatory, Pharmacovigilance, and Medical Affairs in early and mid-stage assets supporting the expansion of Abbvie’s pipeline with opportunities in novel therapeutic areas. Prior to her time at Abbvie, she was the Associate Director, North America Regulatory Affairs at Lung, LLC, a subsidiary of United Therapeutics focusing on rare pulmonary diseases. Ms. Lampe advanced development therapies in Pulmonary Arterial Hypertension leveraging biologics and small molecules. Additionally, she managed external alliance partnerships with public health organizations, advocacy groups, manufacturers, and distributors. Ms. Lampe has a Master of Science in Biomedical Chemistry from Thomas Jefferson University and a Bachelor of Science in Cell/Molecular Biology from Tulane University.